BACKGROUND: Patients taking digoxin are older with high probability of having low muscle mass, and current clinical practice in digoxin dosing relies only on estimated glomerular filtration rate from serum creatinine (eGFRcrea). The aim of the study is to compare eGFRcrea and estimated glomerular filtration rate from serum cystatin C (eGFRcys) in older adult patients with atrial fibrillation (AF) overdosed with digoxin. METHODS: A total of 80 consecutive patients overdosed with digoxin and 33 controls with AF from Department of Internal Medicine were included in the prospective observational study. The median of age of participants was 81 years in both the overdosed and the control group. The eGFRs were calculated using The Chronic Kidney Disease Epidemiology (CKD- EPI) equations using standardized methods for serum creatinine and cystatin C measurement. RESULTS: The median (IQR) of eGFRcrea was higher than that of eGFRcys (45 mL/min/1.73 m2 (35-59) vs 30 (21-38), respectively; P < .0001) in overdosed patients. The median (IQR) of eGFRcrea was higher than that of eGFRcys (61 mL/min/1.73 m2 (49-72) vs 40 (30-56), respectively; P < .0001) in control group of patients. Serum predose digoxin concentration in overdosed patients was inversely associated with eGFRcys (ρ = -0.26, P < .05). CONCLUSION: Physicians should consider GFR when changing digoxin dosing. eGFRcys was lower in both the overdosed and the control group. eGFRcys would lead to lower digoxin doses and thus prevent overdose.

Department of Biomedical sciences Medical Faculty University of Ostrava Ostrava Czech Republic

Department of Clinical Biochemistry and Pharmacology The Tomas Bata Hospital in Zlín Zlín Czech Republic

Department of Internal Medicine The Tomas Bata Hospital in Zlín Zlín Czech Republic

Faculty of Medicine Palacký University Olomouc Olomouc Czech Republic

Pharmacy The Tomas Bata Hospital in Zlín Zlín Czech Republic

See more in PubMed

Reed BN, Sueta CA. A practical guide for the treatment of symptomatic heart failure with reduced ejection fraction (HFrEF). Curr Cardiol Rev. 2015;11:23‐32. PubMed PMC

Grundmann M, Kacířová I. Personalized pharmacotherapy of digoxin. Vnitr̆ Lék. 2015;61:406‐409. PubMed

Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604‐612. PubMed PMC

Kimura K, Morita H, Daimon M, et al. Utility of cystatin c for estimating glomerular filtration rate in patients with muscular dystrophy. Int Heart J. 2016;57:386‐388. PubMed

Bökenkamp A, Laarman CARC, Braam KI, et al. Effect of corticosteroid therapy on low‐molecular–weight protein markers of kidney function. ClinChem. 2007;53:2219‐2221. PubMed

Goede DL, Wiesli P, Brändle M, et al. Effects of thyroxine replacement on serum creatinine and cystatin C in patients with primary and central hypothyroidism. SwissMed Wkly. 2009;139:339‐344. PubMed

Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367:20‐29. PubMed PMC

Dodder NG, Tai SS‐C, Sniegoski LT, et al. Certification of creatinine in a human serum reference material by GC‐MS and LC‐MS. Clin Chem. 2007;53(9):1694‐1699. PubMed

Grubb A, Blirup‐Jensen S, Lindström V, et al. First certified reference material for cystatin C in human serum ERM‐DA471/IFCC. Clin Chem Lab Med. 2010;48:1619‐1621. PubMed

Legrand H, Werner K, Christensson A, Pihlsgård M, Elmståhl S. Prevalenceand determinants of differences in cystatin C and creatinine‐based estimated glomerular filtration rate in community‐dwellingolderadults: a cross‐sectional study. BMC Nephrol. 2017;18:350. PubMed PMC

Wang CH, Rubinsky AD, Minichiello T, Shlipak MG, Price EL. Creatinine versus cystatin C: differing estimates of renal function in hospitalized veterans receiving anticoagulants. J Gen Intern Med. 2018;33:1299‐1306. PubMed PMC

Šálek T, Veselý P, Bernátek J. Estimated glomerular filtration rate in oncology patients before cisplatin chemotherapy. Klin Onkol. 2015;28:273‐277. PubMed

Iversen E, Bodilsen AC, Klausen H, et al. Kidney function estimates using cystatin C versus creatinine: Impact on medication prescribing in acutely hospitalized elderly patients. Basic Clin Pharmacol Toxicol. 2018;124:466‐478. PubMed

Drion I, Cobbaert C, Groenier KH, et al. Clinical evaluation of analytical variations in serum creatinine measurements: why laboratories should abandon Jaffe techniques. BMC Nephrol. 2012;13:133. PubMed PMC

Volpi E, Nazemi R, Fujita S. Muscle tissue changes with aging. Curr Opin Clin Nutr Metab Care. 2004;7:405‐410. PubMed PMC

Sharma D, Hawkins M, Abramowitz MK. Association of Sarcopenia with eGFR and Misclassification of Obesity in Adults with CKD in the United States. Clin J Am Soc Nephrol. 2014;9(12):2079‐2088. PubMed PMC

Rebollo N, Cepeda‐Piorno FJ. Cystatin C for therapeutic drug monitoring. Clin Chem. 2015;61:804‐807. PubMed

Frazee EN, Rule AD, Herrmann SM, et al. Serum cystatin C predicts vancomycin trough levels better than serum creatinine in hospitalized patients: a cohort study. Crit Care (Lond, Engl). 2014;18:110. PubMed PMC

Shlipak MG, Mattes MD, Peralta CA. Update on cystatin C: incorporation into clinical practice. Am J Kidney Dis. 2013;62:595‐603. PubMed PMC

Hallberg P, Melhus H, Hansson LO, Larsson A. Cystatin C vs creatinine as markers of renal function in patients on digoxin treatment. Ups J Med Sci. 2004;109:247‐254. PubMed

Šálek T, Vodička M, Gabrhelík T. Estimated glomerular filtration rate in patients overdosed with gentamicin. J Lab Med. 2020;44:35‐39.

Soveri I, Berg UB, Björk J, et al. Measuring GFR: a systematic review. Am J Kidney Dis. 2014;64:411‐424. PubMed

Vinge E, Lindergård B, Nilsson‐Ehle P, Grubb A. Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults. Scand J Clin Lab Invest. 1999;59:587‐592. PubMed

Nishida K, Hashimoto Y, Kaji A, et al. Creatinine/(cystatin C × body weight) ratio is associated with skeletal muscle mass index. Endocr J. 2020. PubMed

Cystatin C for gentamicin dosing - a case study